US Patent 10544221 Single chain variable fragment CD3 binding proteins
Patent 10544221 was granted and assigned to Harpoon Therapeutics on January, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 19, 2017
Date of Patent
January 28, 2020
Patent Applicant
Patent Application Number
15600264
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10544221 Single chain variable fragment CD3 binding proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.